We established CDH11 knockdown (KD) using shRNA in advanced bladder cancer cell lines and performed analyses of cell proliferation, invasion, and migration; gene expression analysis via RNA‐seq; tumor formation via xenografts; metabolic analysis using the Flux analyzer; and therapeutic effect analysis using low‐molecular‐weight compounds. Here, CDH11 is linked to urinary bladder cancer.